Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 40INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1Dermatologic 1

Conditions

Recurrence 1Multiple Myeloma 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Basal Cell 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Ascorbic Acid × Clear all
NCT02206425 2023-10-31

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

Oncotherapeutics

Phase 1/2 Completed
45 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT05174845 2022-05-31

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

Norgine

Completed
13,393 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms

NCT04279535 2021-11-02

Topical Vitamin C for Treatment of Basal Cell Cancer

Center for Biomedical Research, Inc.

Phase EARLY_PHASE1 Completed
25 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡